Outcomes of bariatric surgery in patients with liver cirrhosis

BARiatric surgery in patients with liver CIRRhOsis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN15009106

Enrollment

Registered

2017-05-26

Start date

2017-06-01

Completion date

Unknown

Last updated

2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Digestive System Obesity

Interventions

This is a retrospective study. Participants are included for this study if they already have had a bariatric surgery and have been followed up since the surgery date until the inclusion data in the st

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient with obesity and liver cirrhosis submitted to bariatric surgery in Spain 2. Aged 18 to 70 years old

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
Short and long term evolution of patients with liver cirrhosis submitted to obesity surgery is measured using patient records at 1 month and one year after bariatric surgery and for long term evolution, at the last visit in each patient	—

Secondary

Measure	Time frame
1. Causes of cirrhosis, staging (Child, MELD) and degree of hepatic insufficiency (albumin, platelets, INR, liver function tests) are measured using patient records at the last pre-surgical visit 2. Hepatic pathology after bariatric surgery (staging (Child, MELD), degree of liver failure (albumin, platelets, INR, liver function tests), liver biopsies, hepatic decompensations postIQ (encephalopathy, ascites, Bleeding), development of hepatocarcinoma)) are measured using patient records at the patients last follow up visit 3. Frequency of early complications are measured using patient records at early postoperative ( 30 days post surgery) 4. Obesity comorbidities (diabetes, hypertension, dyslipidemia, SAHS) are measured using patient records at the last pre-surgical visit and at each year after surgery until study inclusion 5. Body weight is measured using patient records at the last pre-surgical visit and at each year after surgery until study inclusion	—

Measure

Time frame

1. Causes of cirrhosis, staging (Child, MELD) and degree of hepatic insufficiency (albumin, platelets, INR, liver function tests) are measured using patient records at the last pre-surgical visit 2. Hepatic pathology after bariatric surgery (staging (Child, MELD), degree of liver failure (albumin, platelets, INR, liver function tests), liver biopsies, hepatic decompensations postIQ (encephalopathy, ascites, Bleeding), development of hepatocarcinoma)) are measured using patient records at the patients last follow up visit 3. Frequency of early complications are measured using patient records at early postoperative ( 30 days post surgery) 4. Obesity comorbidities (diabetes, hypertension, dyslipidemia, SAHS) are measured using patient records at the last pre-surgical visit and at each year after surgery until study inclusion 5. Body weight is measured using patient records at the last pre-surgical visit and at each year after surgery until study inclusion

—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026